Weiss Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-28,350
Closed -$403K – 395
2022
Q4
$403K Buy
+28,350
New +$411K 0.02% 380
2022
Q1
– Sell
-19,624
Closed -$377K – 833
2021
Q4
$377K Buy
+19,624
New +$395K 0.01% 568
2019
Q2
– Sell
-23,143
Closed -$396K – 381
2019
Q1
$396K Sell
23,143
-7,682
-25% -$133K 0.03% 127
2018
Q4
$466K Buy
+30,825
New +$543K 0.03% 220
2018
Q1
– Sell
-18,876
Closed -$371K – 277
2017
Q4
$371K Buy
+18,876
New +$378K 0.03% 146
2017
Q1
– Sell
-12,538
Closed -$213K – 134
2016
Q4
$213K Buy
+12,538
New +$220K 0.03% 128
2016
Q1
– Sell
-10,036
Closed -$237K – 143
2015
Q4
$237K Buy
+10,036
New +$249K 0.06% 175
2014
Q3
– Sell
-108,203
Closed -$2.25M – 44
2014
Q2
$2.25M Buy
+108,203
New +$2.27M 1.55% 14

Other funds holding HQL

Weiss Asset Management's HQL Position: Q1 2023 in Review

Weiss Asset Management sold out of abrdn Life Sciences Investors (HQL) in Q1 2023, closing a stake of 28,350 shares — an estimated $403K sold.

Weiss Asset Management first reported a position in HQL in Q2 2014 and held it in 8 quarters. The position peaked at $2.25M in Q2 2014. 78 funds tracked by Wall St. Rank hold HQL as of Q1 2023.

  • Weiss Asset Management reported no remaining abrdn Life Sciences Investors position as of Q1 2023 after selling out during the quarter.
  • Weiss Asset Management sold 28,350 abrdn Life Sciences Investors shares in Q1 2023, an estimated $403K.
  • Weiss Asset Management first reported a position in abrdn Life Sciences Investors in Q2 2014 and held it in 8 quarters.
  • Weiss Asset Management's abrdn Life Sciences Investors position peaked at $2.25M in Q2 2014.
  • 78 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2023.

Based on Weiss Asset Management's 13F filing for Q1 2023, filed 10 May 2023.